Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2026-06-12 @ 5:53 AM
Study NCT ID:
NCT01364727
Status:
COMPLETED
Last Update Posted:
2019-04-16
First Post:
2011-05-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Sponsor:
Heather Wakelee
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB-20444
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |